Kinetic modeling of florbetaben binding to beta-amyloid in human brains using one and two input functions. - Georg A. Becker; Masanori Ichise; Henryk Barthel; Julia Luthardt; Marianne Patt; Marcus Schultze-Mosgau; Cornelia Reininger; Ulrich Hegerl; Hermann Josef Gertz; Osama Sabri (NeuroImage, 2010)

Compartment-model based quantification of beta-amyloid binding with Florbetaben PET in Alzheimer's disease and control subjects. - Masanori Ichise; Georg A. Becker; Henryk Barthel; Marianne Patt; Julia Luthardt; Hermann Josef Gertz; Marcus Schultze-Mosgau; Beate Rohde; Cornelia Reininger; Osama Sabri (NeuroImage, 2010)

Impact of EEG-vigilance on brain glucose uptake measured with [18F]FDG and PET in patients with depressive episode or mild cognitive impairment. - Thomas Günther; Peter Schönknecht; Georg A. Becker; Sebastian Olbrich; Christian Sander; Swen Hesse; Philipp M. Meyer; Julia Luthardt; Ulrich Hegerl; Osama Sabri (NeuroImage, 2011)

First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[18F]Flubatine. - Osama Sabri; Georg-Alexander Becker; Philipp M. Meyer; Swen Hesse; Stephan Wilke; Susanne Graef; Marianne Patt; Julia Luthardt; Gudrun Wagenknecht; Alexander Hoepping; René Smits; Annegret Franke; et al. (NeuroImage, 2015)